Peritoneal Nebulization of Ropivacaine for Pain Control After Laparoscopic Colectomy
A Multicentric, Randomized, Controlled, Double Blinded, Phase III Clinical Trial; Comparing Peritoneal Nebulization of Ropivacaine 150 mg With Peritoneal Nebulization of Saline
Sponsor: Azienda Ospedaliera di Lecco
Terminated
There was insuficient recruitment in two centers
Listed as NCT01432496, this PHASE3 trial focuses on Postoperative Pain and remains terminated or withdrawn. Sponsored by Azienda Ospedaliera di Lecco, it has been updated 5 times since 2011, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
5 versions recorded-
Sep 2024 — Present [monthly]
Terminated PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Terminated PHASE3
-
Jan 2021 — Jul 2024 [monthly]
Terminated PHASE3
-
Jun 2018 — Jan 2021 [monthly]
Terminated PHASE3
-
Jan 2017 — Jun 2018 [monthly]
Terminated PHASE3
First recorded
Sep 2011
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Azienda Ospedaliera di Lecco
- Fondazione IRCCS Policlinico San Matteo di Pavia
- San Gerardo Hospital
- University of Milano Bicocca
- University of Pavia
For direct contact, visit the study record on ClinicalTrials.gov .